Suppr超能文献

罗马尼亚利什曼病概述:诊断与治疗

An Overview on Leishmaniasis in Romania: Diagnosis and Therapeutics.

作者信息

Daraban Bocaneti Florentina, Ivanescu Larisa Maria, Miron Liviu, Tanase Oana Irina, Dascalu Mihaela Anca

机构信息

Department of Public Health, Faculty of Veterinary Medicine, Iasi University of Life Sciences Ion Ionescu de la Brad, 700489 Iasi, Romania.

Department of Clinics, Faculty of Veterinary Medicine, Iasi University of Life Sciences Ion Ionescu de la Brad, 700489 Iasi, Romania.

出版信息

Trop Med Infect Dis. 2022 Oct 28;7(11):334. doi: 10.3390/tropicalmed7110334.

Abstract

Leishmaniasis, a vector-borne disease considered to be one of the twenty neglected diseases by the World Health Organization, represents one of the public health concerns in endemic countries. In humans, as well as in animal counterparts, the infection can evolve with different clinical localizations, such as those that are cutaneous, mucocutaneous and visceral. Romania has been traditionally considered a nonendemic country for species infection and has had sporadic positive human cases; however, the climate change recorded in recent decades has created potentially optimal conditions for the preponderant vectors of spp., which has lately been identified in various parts of country. Moreover, with people and dogs (the prevailing hosts) traveling in endemic countries, the disease was imported and diagnosed in both species, and became a medical concern. In this review, we focused on the: (1) epidemiological data of leishmaniasis cases, both in humans and animals, reported by Romania; (2) diagnostic tools available for confirmation since there is a lack of gold-standard laboratory methods for human and dog patients; and (3) conventional antileishmanial therapy.

摘要

利什曼病是一种由媒介传播的疾病,被世界卫生组织视为20种被忽视的疾病之一,是流行国家关注的公共卫生问题之一。在人类以及动物中,感染会随着不同的临床定位而发展,例如皮肤型、黏膜皮肤型和内脏型。罗马尼亚传统上被认为是一个没有该物种感染的国家,仅有零星的人类阳性病例;然而,近几十年来记录的气候变化为该物种的主要传播媒介创造了潜在的最佳条件,最近在该国各地都发现了这种媒介。此外,随着人和狗(主要宿主)前往流行国家,这种疾病被输入并在这两个物种中被诊断出来,成为一个医学问题。在本综述中,我们重点关注:(1)罗马尼亚报告的人类和动物利什曼病病例的流行病学数据;(2)由于缺乏针对人类和犬类患者的金标准实验室方法而可用于确诊的诊断工具;以及(3)传统的抗利什曼治疗方法。

相似文献

本文引用的文献

1
An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis.米替福新治疗利什曼病的临床药理学研究进展。
Int J Antimicrob Agents. 2022 Jan;59(1):106459. doi: 10.1016/j.ijantimicag.2021.106459. Epub 2021 Oct 23.
2
Advancement in leishmaniasis diagnosis and therapeutics: An update.利什曼病诊断和治疗的进展:更新。
Eur J Pharmacol. 2021 Nov 5;910:174436. doi: 10.1016/j.ejphar.2021.174436. Epub 2021 Aug 21.
5
Recent advances and new strategies on leishmaniasis treatment.利什曼病治疗的最新进展和新策略。
Appl Microbiol Biotechnol. 2020 Nov;104(21):8965-8977. doi: 10.1007/s00253-020-10856-w. Epub 2020 Sep 2.
6
Recent advances and new strategies in Leishmaniasis diagnosis.利什曼病诊断的最新进展与新策略
Appl Microbiol Biotechnol. 2020 Oct;104(19):8105-8116. doi: 10.1007/s00253-020-10846-y. Epub 2020 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验